c-Jun, at the crossroad of the signaling network

Abstractc-Jun, the most extensively studied protein of the activator protein-1 (AP-1) complex, is involved in numerous cell activities, such as proliferation, apoptosis, survival, tumorigenesis and tissue morphogenesis. Earlier studies focused on the structure and function have led to the identification of c-Jun as a basic leucine zipper (bZIP) transcription factor that acts as homo- or heterodimer, binding to DNA and regulating gene transcription. Later on, it was shown that extracellular signals can induce post-translational modifications of c-Jun, resulting in altered transcriptional activity and target gene expression. More recent work has uncovered multiple layers of a complex regulatory scheme in which c-Jun is able to crosstalk, amplify and integrate different signals for tissue development and disease. One example of such scheme is the autocrine amplification loop, in which signal-induced AP-1 activates the c-Jun gene promoter, while increased c-Jun expression feedbacks to potentiate AP-1 activity. Another example of such scheme, based on recent characterization of gene knockout mice, is that c-Jun integrates signals of several developmental pathways, including EGFR-ERK, EGFR-RhoA-ROCK, and activin B-MAP3K1-JNK for embryonic eyelid closure. After more than two decades of extensive research, c-Jun remains at the center stage of a molecular network with mysterious functional properties, some of which are yet to be discovered. In this article, we will provide a brief historical overview of studies on c-Jun regulation and function, and use eyelid development as an example to illustrate the complexity of c-Jun crosstalking with signaling pathways.

[1]  A. Kraft,et al.  Affinity-purified c-Jun amino-terminal protein kinase requires serine/threonine phosphorylation for activity. , 1992, The Journal of biological chemistry.

[2]  C. Sutherland,et al.  Phosphorylation of caldesmon by smooth-muscle casein kinase II , 1994, Journal of Muscle Research & Cell Motility.

[3]  J. Woodgett,et al.  The stress-activated protein kinase subfamily of c-Jun kinases , 1994, Nature.

[4]  R. Lang,et al.  Mitogen-activated protein kinase kinase kinase 1 (MAP3K1) integrates developmental signals for eyelid closure , 2011, Proceedings of the National Academy of Sciences.

[5]  R. Tjian,et al.  Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. , 1987, Science.

[6]  M. Isobe,et al.  Localization of the human JUN protooncogene to chromosome region 1p31-32. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[7]  I. Weinstein,et al.  Protein Kinase G Activates the JNK1 Pathway via Phosphorylation of MEKK1* , 2001, The Journal of Biological Chemistry.

[8]  S. McKnight,et al.  The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. , 1988, Science.

[9]  A. Papavassiliou,et al.  Phosphorylation state and DNA-binding activity of c-Jun depend on the intracellular concentration of binding sites. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C. Deng,et al.  FGF-regulated BMP signaling is required for eyelid closure and to specify conjunctival epithelial cell fate , 2009, Development.

[11]  M. Karin,et al.  Rapid and preferential activation of the c-jun gene during the mammalian UV response , 1991, Molecular and cellular biology.

[12]  E. Wagner,et al.  Psoriasis: what we have learned from mouse models , 2010, Nature Reviews Rheumatology.

[13]  R. Tjian,et al.  Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements , 1987, Cell.

[14]  T. Nakamura,et al.  Regulation of jun and fos gene expression in human monocytes by the macrophage colony-stimulating factor. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[15]  G. Mordret MAP kinase kinase: A node connecting multiple pathways , 1993, Biology of the cell.

[16]  S. Pelech,et al.  Identification of Two Essential Phosphorylated Threonine Residues In the Catalytic Domain of Mekk1 , 1997, The Journal of Biological Chemistry.

[17]  L. Zon,et al.  Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1 , 1994, Nature.

[18]  Jinke Wang,et al.  c-Jun binding site identification in K562 cells. , 2011, Journal of genetics and genomics = Yi chuan xue bao.

[19]  P. Higgins,et al.  PAI‐1 expression is required for epithelial cell migration in two distinct phases of in vitro wound repair , 2004, Journal of cellular physiology.

[20]  T Takahashi,et al.  ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis , 2001, EMBO reports.

[21]  D. Gillespie,et al.  Protein phosphatase 2A reverses phosphorylation of c-Jun specified by the delta domain in vitro: correlation with oncogenic activation and deregulated transactivation activity of v-Jun. , 1991, Oncogene.

[22]  Jiahuai Han,et al.  Axin Forms a Complex with MEKK1 and Activates c-Jun NH2-terminal Kinase/Stress-activated Protein Kinase through Domains Distinct from Wnt Signaling* , 1999, The Journal of Biological Chemistry.

[23]  David C. Lee,et al.  TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice , 1993, Cell.

[24]  M. Karin Signal transduction and gene control. , 1991, Current opinion in cell biology.

[25]  Zhengquan Yu,et al.  Grainyhead-like factor Get1/Grhl3 regulates formation of the epidermal leading edge during eyelid closure. , 2008, Developmental biology.

[26]  E. Wagner,et al.  c-Jun regulates eyelid closure and skin tumor development through EGFR signaling. , 2003, Developmental cell.

[27]  M. Karin,et al.  A role for MEK kinase 1 in TGF‐β/activin‐induced epithelium movement and embryonic eyelid closure , 2003, The EMBO journal.

[28]  J. Woodgett,et al.  Glycogen synthase kinase 3 phosphorylates Jun family members in vitro and negatively regulates their transactivating potential in intact cells. , 1993, Oncogene.

[29]  D. Nathans,et al.  Induction of protooncogene c-jun by serum growth factors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. Kollias,et al.  TNF-α Induction by LPS Is Regulated Posttranscriptionally via a Tpl2/ERK-Dependent Pathway , 2000, Cell.

[31]  Melynda Boerm,et al.  Mekk3 is essential for early embryonic cardiovascular development , 2000, Nature Genetics.

[32]  P. Vogt,et al.  v-jun encodes a nuclear protein with enhancer binding properties of AP-1 , 1988, Cell.

[33]  D. Cohen,et al.  Overexpression of fra-2 in transgenic mice perturbs normal eye development , 1998, Oncogene.

[34]  H. Saya,et al.  The Anaphase-Promoting Complex/Cyclosome Activator Cdh1 Modulates Rho GTPase by Targeting p190 RhoGAP for Degradation , 2010, Molecular and Cellular Biology.

[35]  D. Kufe,et al.  Transcriptional and post-transcriptional regulation of c-jun expression during monocytic differentiation of human myeloid leukemic cells. , 1990, The Journal of biological chemistry.

[36]  G L Johnson,et al.  Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. , 1994, Science.

[37]  G. Johnson,et al.  Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases , 2002, Science.

[38]  E. Wagner,et al.  Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation , 1999, Nature Genetics.

[39]  C. Venot,et al.  Grb2 Interaction with MEK-Kinase 1 Is Involved in Regulation of Jun-Kinase Activities in Response to Epidermal Growth Factor* , 1998, The Journal of Biological Chemistry.

[40]  Tony Hunter,et al.  Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity , 1991, Cell.

[41]  Liang Chen,et al.  Differential transmission of MEKK1 morphogenetic signals by JNK1 and JNK2 , 2007, Development.

[42]  M. Schumacher,et al.  The Structure of a CREB bZIP·Somatostatin CRE Complex Reveals the Basis for Selective Dimerization and Divalent Cation-enhanced DNA Binding* , 2000, The Journal of Biological Chemistry.

[43]  M. Karin,et al.  The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. , 1991, Biochimica et biophysica acta.

[44]  T. Tan,et al.  Activation of the c-Jun N-terminal kinase pathway by a novel protein kinase related to human germinal center kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Cobb,et al.  RhoA Binds to the Amino Terminus of MEKK1 and Regulates Its Kinase Activity* , 2004, Journal of Biological Chemistry.

[46]  M. Karin,et al.  Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. , 1995, Science.

[47]  Phillip A. Sharp,et al.  6 – Regulation of Transcription , 1991 .

[48]  B. Franza,et al.  Fos and Jun bind cooperatively to the AP-1 site: reconstitution in vitro. , 1988, Genes & development.

[49]  Jiahuai Han,et al.  NIK is a new Ste20‐related kinase that binds NCK and MEKK1 and activates the SAPK/JNK cascade via a conserved regulatory domain , 1997, The EMBO journal.

[50]  K. Alitalo,et al.  Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation , 1989, Molecular and cellular biology.

[51]  R. Davis,et al.  MAPKs: new JNK expands the group. , 1994, Trends in biochemical sciences.

[52]  C. Pritchard,et al.  MEK kinase activity is not necessary for Raf‐1 function , 2001, The EMBO journal.

[53]  T. Hunter,et al.  Oncogene jun encodes a sequence-specific trans- activator similar to AP-1 , 1988, Nature.

[54]  S. Narumiya,et al.  ROCK‐I and ROCK‐II cooperatively regulate closure of eyelid and ventral body wall in mouse embryo , 2005, Genes to cells : devoted to molecular & cellular mechanisms.

[55]  G. Kollias,et al.  TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. , 2000, Cell.

[56]  R. Tjian,et al.  Fos-associated protein p39 is the product of the jun proto-oncogene. , 1988, Science.

[57]  J. Arbeit,et al.  c-Jun is essential for organization of the epidermal leading edge. , 2003, Developmental cell.

[58]  F. Grosveld,et al.  Regulation of Transcription , 2007 .

[59]  K. Struhl,et al.  The GCN4 basic region leucine zipper binds DNA as a dimer of uninterrupted α Helices: Crystal structure of the protein-DNA complex , 1992, Cell.

[60]  B. Su,et al.  Disruption of Mekk2 in Mice Reveals an Unexpected Role for MEKK2 in Modulating T-Cell Receptor Signal Transduction , 2002, Molecular and Cellular Biology.

[61]  C. S. Parker,et al.  Transcriptional activation by the SV40 AP-1 recognition element in yeast is mediated by a factor similar to AP-1 that is distinct from GCN4 , 1988, Cell.

[62]  R. Grose Epithelial migration: open your eyes to c-Jun , 2003, Current Biology.

[63]  J. Molkentin,et al.  MEKK1 Transduces Activin Signals in Keratinocytes To Induce Actin Stress Fiber Formation and Migration , 2005, Molecular and Cellular Biology.

[64]  P. Rakic,et al.  Loss of mitogen-activated protein kinase kinase kinase 4 (MEKK4) results in enhanced apoptosis and defective neural tube development. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[65]  E. Wagner,et al.  Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation , 2000, Oncogene.

[66]  G. Johnson,et al.  The TAO of MEKK. , 1998, Frontiers in bioscience : a journal and virtual library.

[67]  R. Breathnach,et al.  Epidermal growth factor stimulates transcription of the c-jun proto-oncogene in rat fibroblasts , 1988, Nature.

[68]  M. Karin,et al.  JNKK1 organizes a MAP kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extension. , 1998, Genes & development.

[69]  S. Tapscott,et al.  Functional antagonism between c-Jun and MyoD proteins: A direct physical association , 1992, Cell.

[70]  A. Kraft,et al.  In vitro association between the Jun protein family and the general transcription factors, TBP and TFIIB. , 1995, The Biochemical journal.

[71]  Myong-Hee Sung,et al.  Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. , 2011, Molecular cell.

[72]  D. Schlessinger,et al.  Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. , 2004, Human molecular genetics.

[73]  M. Karin,et al.  Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73 , 1991, Nature.

[74]  O. Smithies,et al.  TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. , 1993, Cell.

[75]  E. Zandi,et al.  AP-1 function and regulation. , 1997, Current opinion in cell biology.

[76]  E. Wagner,et al.  c-Jun Controls Histone Modifications, NF-κB Recruitment, and RNA Polymerase II Function To Activate the ccl2 Gene , 2008, Molecular and Cellular Biology.

[77]  P. Rakic,et al.  The Jnk1 and Jnk2 Protein Kinases Are Required for Regional Specific Apoptosis during Early Brain Development , 1999, Neuron.

[78]  D. Templeton,et al.  Regulation of the activity of MEK kinase 1 (MEKK1) by autophosphorylation within the kinase activation domain. , 1997, The Biochemical journal.

[79]  B. Spiegelman,et al.  A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. , 1993, Genes & development.

[80]  K. Tyler,et al.  MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[81]  N. Short Are some controlling factors more equal than others? , 1987, Nature.

[82]  M. Kaufman,et al.  Eyelid development, fusion and subsequent reopening in the mouse. , 1993, Journal of anatomy.

[83]  M. Karin,et al.  AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.

[84]  M. Cobb,et al.  MEKK1 interacts with alpha-actinin and localizes to stress fibers and focal adhesions. , 1999, Cell motility and the cytoskeleton.

[85]  C L Carpenter,et al.  c-Jun is a JNK-independent coactivator of the PU.1 transcription factor. , 1999, The Journal of biological chemistry.

[86]  P. Vogt,et al.  Avian sarcoma virus 17 carries the jun oncogene. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[87]  Peter Angel,et al.  The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1 , 1988, Cell.

[88]  Dianqing Wu,et al.  The canonical Wnt signaling antagonist DKK2 is an essential effector of PITX2 function during normal eye development. , 2008, Developmental biology.

[89]  T. Toda,et al.  Fission yeast genes that confer resistance to staurosporine encode an AP-1-like transcription factor and a protein kinase related to the mammalian ERK1/MAP2 and budding yeast FUS3 and KSS1 kinases. , 1991, Genes & development.

[90]  M. Karin,et al.  Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73 , 1992, Molecular and cellular biology.

[91]  R. Davis,et al.  Evidence for a Role of Rho-like GTPases and Stress-activated Protein Kinase/c-Jun N-terminal Kinase (SAPK/JNK) in Transforming Growth Factor β-mediated Signaling* , 1997, The Journal of Biological Chemistry.

[92]  D. Brenner,et al.  Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity , 1992, Cell.

[93]  E. Mekada,et al.  HB-EGF promotes epithelial cell migration in eyelid development , 2005, Development.

[94]  M. Karin,et al.  JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain , 1994, Cell.

[95]  C. Lange-Carter,et al.  A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf , 1993, Science.

[96]  L. Lau,et al.  A gene activated by growth factors is related to the oncogene v-jun. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[97]  M. Cobb,et al.  Cloning of rat MEK kinase 1 cDNA reveals an endogenous membrane-associated 195-kDa protein with a large regulatory domain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[98]  M. Karin,et al.  Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. , 1993, Genes & development.

[99]  D. Bohmann Transcription factor phosphorylation: a link between signal transduction and the regulation of gene expression. , 1990, Cancer cells.

[100]  I. Verma,et al.  Induction of proto-oncogene JUN/AP-1 by serum and TPA , 1988, Nature.

[101]  F. Kokocinski,et al.  Identification of novel AP-1 target genes in fibroblasts regulated during cutaneous wound healing , 2004, Oncogene.

[102]  Tsonwin Hai,et al.  A family of immunologically related transcription factors that includes multiple forms of ATF and AP-1. , 1988, Genes & development.

[103]  D. Luk,et al.  Jun is phosphorylated by several protein kinases at the same sites that are modified in serum-stimulated fibroblasts , 1992, Molecular and cellular biology.

[104]  J. Woodgett,et al.  Phorbol ester-induced amino-terminal phosphorylation of human JUN but not JUNB regulates transcriptional activation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.